• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

2020 Virtual Care: Navigating Patient Care In A Post-COVID-19 World

Share:

September 16, 2020

Updox, the only place to manage healthcare communications across both in-person and virtual care, today released its 2020 Virtual Care Report: Patient Care in a Post-COVID World that details the rapid transformation telehealth saw during COVID-19, how it is currently being used, physician and patient expectations for telehealth post-COVID — and how virtual care spanning the entire patient experience will become the new precedent.

At the start of the COVID-19 pandemic, telehealth became the new norm almost overnight. According to new survey data by Updox, while most practices and health systems had already employed some type of technology to manage patient intake and appointment reminders, only 18.7% offered telehealth. Once COVID hit, however, providers saw an urgent need to connect with their patients and provide care in a safe and effective way, and doing so was their primary concern. As a result, 93.8% of providers reported offering telehealth.

Today, providers who implemented telehealth via Updox are more certain that they will be back up and running in two to six months compared to those who selected another partner for telehealth (45.9% vs 34.8%). In fact, some practices that leveraged Updox telehealth retained upwards of 75% of their normal patient volume during COVID despite offices being physically closed. Looking ahead, more than 56 percent of Updox survey respondents report telehealth to be very to extremely important to the future of their practice, and more than 95% report they plan to offer telehealth in the future.

“COVID-19 has forever changed the delivery of healthcare. In a post-COVID environment, telehealth is no longer a novelty – it is a requirement to stay in business. But telehealth is just one piece of a successful practice,” said Michael Morgan, CEO, Updox. “Looking ahead, providers must expand their offerings to include a mix of in-person and virtual visits. In doing so, physicians can ultimately be more productive, engage with a larger number of patients and run a highly profitable practice.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Post-COVID Expectations and the Future of Virtual Care

Moving forward, patient expectations for on-demand, convenient healthcare will continue to take precedent. Practicing healthcare in a post-COVID environment will require a virtual care strategy throughout the entire practice workflow that is not only cost-effective and resource-efficient, but that improves the patient experience both inside and out of the practice. This encompasses all patient engagement solutions such as video chat, secure text, electronic fax, patient reminders, and touchless billing.

“Developing a virtual care strategy is imperative to a more comprehensive patient experience, improved outcomes and the long-term success of healthcare practices, but permanent reimbursement of telehealth is key to making this happen,” continued Morgan. “Healthcare has forever changed since the start of 2020, and reimbursement needs to follow suit. Patients are demanding safety, convenience, and choice when it comes to healthcare delivery. Telehealth will continue to play a critical role moving forward, and the industry needs to support their professional associations, contact congressional leaders and speak out about payment reform.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Sony Unveils Wearable for Secure Mobile Health & Remote MonitoringSony Unveils Wearable for Secure Mobile Health & Remote Monitoring
  • PE-backed Guidehouse to acquire NavigantPE-backed Guidehouse to acquire Navigant
  • Charles River Labs to Acquire HemaCare for $380M, Expanding Presence in Cell TherapyCharles River Labs to Acquire HemaCare for $380M, Expanding Presence in Cell Therapy
  • Integrity Marketing Group Continues Pace With Acquisition Of Pinnacle Benefits GroupIntegrity Marketing Group Continues Pace With Acquisition Of Pinnacle Benefits Group
  • Florida Health System to Implement Fully Digital Patient Smart RoomsFlorida Health System to Implement Fully Digital Patient Smart Rooms
  • American Medical Technologies Announces Acquisition by One Equity Partners and The Silverfern GroupAmerican Medical Technologies Announces Acquisition by One Equity Partners and The Silverfern Group
  • PTC Therapeutics to Acquire Agilis BiotherapeuticsPTC Therapeutics to Acquire Agilis Biotherapeutics
  • Nuance Integrates with Microsoft Teams for Virtual Telehealth ConsultsNuance Integrates with Microsoft Teams for Virtual Telehealth Consults

Trending This Week

  • Pharmaceutical Compliance Software Market 2022 to Showing Impressive Growth By | [no. of Pages: 118] Industry Trends, Share, Size, Top Key Players Analysis and Forecast Research, Shares and Strategies | By Proficient Market Insights
  • Biosimilars Market: Rise in Number of Cancer Patients to Boost Market
  • Biotechnology and Pharmaceutical Services Outsourcing Market Size 2022 Analysis Report By Competitive Vendors in Top Regions and Countries, Production Types, Applications, Growth, Current Trends and Forecast to 2026
  • The Global Wearable Injectors Market Size is Expected to Reach $12.9 Billion By 2028, Rising at a Market Growth of 9.2% CAGR During the Forecast Period
  • Treprostinil Drugs Market – Insights on how Players Have Cemented Their Positions with Disruptive Technologies, Key Players are United Therapeutics, Novartis, and Teva Pharmaceutical Industries Ltd
  • Protect Pharmaceutical Corporation has Acquired Top Notch Software Development Company

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications